The role of naloxegol in the management of opioid-induced bowel dysfunction
Opioid-induced constipation (OIC) and other gastrointestinal (GI) symptoms of opioid-induced bowel dysfunction (OIBD) significantly deteriorate patients’ quality of life and may lead to noncompliance with opioid schedule and undertreatment of pain. Although traditional oral laxatives are the first-l...
Main Authors: | Wojciech Leppert, Jaroslaw Woron |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2016-09-01
|
Series: | Therapeutic Advances in Gastroenterology |
Online Access: | https://doi.org/10.1177/1756283X16648869 |
Similar Items
-
Clinical potential of naloxegol in the management of opioid-induced bowel dysfunction
by: Poulsen JL, et al.
Published: (2014-09-01) -
Clinical utility of naloxegol in the treatment of opioid-induced constipation
by: Bruner HC, et al.
Published: (2015-06-01) -
Emerging therapies for patients with symptoms of opioid-induced bowel dysfunction
by: Leppert W
Published: (2015-04-01) -
Naloxegol in opioid-induced constipation: a new paradigm in the treatment of a common problem
by: Yoon SC, et al.
Published: (2017-07-01) -
Perioperative Immunosuppression and Risk of Cancer Progression: The Impact of Opioids on Pain Management
by: Renata Zajączkowska, et al.
Published: (2018-01-01)